Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 154

Similar articles for PubMed (Select 22396600)


Transmembrane domain membrane proximal external region but not surface unit-directed broadly neutralizing HIV-1 antibodies can restrict dendritic cell-mediated HIV-1 trans-infection.

Sagar M, Akiyama H, Etemad B, Ramirez N, Freitas I, Gummuluru S.

J Infect Dis. 2012 Apr 15;205(8):1248-57. doi: 10.1093/infdis/jis183. Epub 2012 Mar 6.


Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies.

Pritchard LK, Spencer DI, Royle L, Bonomelli C, Seabright GE, Behrens AJ, Kulp DW, Menis S, Krumm SA, Dunlop DC, Crispin DJ, Bowden TA, Scanlan CN, Ward AB, Schief WR, Doores KJ, Crispin M.

Nat Commun. 2015 Jun 24;6:7479. doi: 10.1038/ncomms8479.


Inhibitory effect of individual or combinations of broadly neutralizing antibodies and antiviral reagents against cell-free and cell-to-cell HIV-1 transmission.

Gombos RB, Kolodkin-Gal D, Eslamizar L, Owuor JO, Mazzola E, Gonzalez AM, Korioth-Schmitz B, Gelman RS, Montefiori DC, Haynes BF, Schmitz JE.

J Virol. 2015 May 20. pii: JVI.00783-15. [Epub ahead of print]


Correction for Doores et al., Two Classes of Broadly Neutralizing Antibodies within a Single Lineage Directed to the High-Mannose Patch of HIV Envelope.

Doores KJ, Kong L, Krumm SA, Le KM, Sok D, Laserson U, Garces F, Poignard P, Wilson IA, Burton DR.

J Virol. 2015 Jun 15;89(12):6525. doi: 10.1128/JVI.00593-15. No abstract available.


Adenovirus-vectored broadly neutralizing antibodies directed against gp120 prevent HIV-1 acquisition in humanized mice.

Liu S, Jackson A, Beloor J, Kumar P, Sutton R.

Hum Gene Ther. 2015 May 8. [Epub ahead of print]


Correction: CD169-Mediated Trafficking of HIV to Plasma Membrane Invaginations in Dendritic Cells Attenuates Efficacy of Anti-gp120 Broadly Neutralizing Antibodies.

PLOS Pathogens Staff.

PLoS Pathog. 2015 May 7;11(5):e1004916. doi: 10.1371/journal.ppat.1004916. eCollection 2015 May. No abstract available.


Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas.

Barbian HJ, Decker JM, Bibollet-Ruche F, Galimidi RP, West AP Jr, Learn GH, Parrish NF, Iyer SS, Li Y, Pace CS, Song R, Huang Y, Denny TN, Mouquet H, Martin L, Acharya P, Zhang B, Kwong PD, Mascola JR, Verrips CT, Strokappe NM, Rutten L, McCoy LE, Weiss RA, Brown CS, Jackson R, Silvestri G, Connors M, Burton DR, Shaw GM, Nussenzweig MC, Bjorkman PJ, Ho DD, Farzan M, Hahn BH.

MBio. 2015 Apr 21;6(2). pii: e00296-15. doi: 10.1128/mBio.00296-15.


Dressing up Nanoparticles: A Membrane Wrap to Induce Formation of the Virological Synapse.

Yu X, Xu F, Ramirez NG, Kijewski SD, Akiyama H, Gummuluru S, Reinhard BM.

ACS Nano. 2015 Apr 28;9(4):4182-92. doi: 10.1021/acsnano.5b00415. Epub 2015 Apr 14.


Monoclonal And Single Domain Antibodies Targeting β -Integrin Subunits Block Sexual Transmission of HIV-1 in in vitro and in vivo Model Systems.

Guedon JT, Luo K, Zhang H, Markham RB.

J Acquir Immune Defic Syndr. 2015 Mar 28. [Epub ahead of print]


Pharmacokinetics and immunogenicity of broadly neutralizing HIV monoclonal antibodies in macaques.

Rosenberg Y, Sack M, Montefiori D, Labranche C, Lewis M, Urban L, Mao L, Fischer R, Jiang X.

PLoS One. 2015 Mar 25;10(3):e0120451. doi: 10.1371/journal.pone.0120451. eCollection 2015.


Report of the 2014 Cent Gardes HIV Vaccine Conference - Part 1: Neutralizing Antibodies; Fondation Mérieux Conference Center, Veyrier du Lac, France, 5-7 October 2014.

Girard MP, Picot V, Longuet C, Nabel GJ.

Vaccine. 2015 Mar 11. pii: S0264-410X(15)00290-X. doi: 10.1016/j.vaccine.2015.03.004. [Epub ahead of print]


CD169-mediated trafficking of HIV to plasma membrane invaginations in dendritic cells attenuates efficacy of anti-gp120 broadly neutralizing antibodies.

Akiyama H, Ramirez NG, Gudheti MV, Gummuluru S.

PLoS Pathog. 2015 Mar 11;11(3):e1004751. doi: 10.1371/journal.ppat.1004751. eCollection 2015 Mar.


Neutralisation of HIV-1 cell-cell spread by human and llama antibodies.

McCoy LE, Groppelli E, Blanchetot C, de Haard H, Verrips T, Rutten L, Weiss RA, Jolly C.

Retrovirology. 2014 Oct 2;11:83. doi: 10.1186/s12977-014-0083-y.


Placental Hofbauer cells assemble and sequester HIV-1 in tetraspanin-positive compartments that are accessible to broadly neutralizing antibodies.

Johnson EL, Chu H, Byrareddy SN, Spearman P, Chakraborty R.

J Int AIDS Soc. 2015 Jan 22;18(1):19385. doi: 10.7448/IAS.18.1.19385. eCollection 2015.


Virological features associated with the development of broadly neutralizing antibodies to HIV-1.

Moore PL, Williamson C, Morris L.

Trends Microbiol. 2015 Apr;23(4):204-11. doi: 10.1016/j.tim.2014.12.007. Epub 2015 Jan 5. Review.


Designer antigens for elicitation of broadly neutralizing antibodies against HIV.

Kok T, Gaeguta A, Finnie J, Gorry PR, Churchill M, Li P.

Clin Transl Immunology. 2014 Sep 26;3(9):e24. doi: 10.1038/cti.2014.22. eCollection 2014 Sep.


Synergy in monoclonal antibody neutralization of HIV-1 pseudoviruses and infectious molecular clones.

Miglietta R, Pastori C, Venuti A, Ochsenbauer C, Lopalco L.

J Transl Med. 2014 Dec 13;12(1):346. doi: 10.1186/s12967-014-0346-3.


Escherichia coli surface display of single-chain antibody VRC01 against HIV-1 infection.

Wang LX, Mellon M, Bowder D, Quinn M, Shea D, Wood C, Xiang SH.

Virology. 2015 Jan 15;475:179-86. doi: 10.1016/j.virol.2014.11.018. Epub 2014 Dec 5.


Polyreactivity and autoreactivity among HIV-1 antibodies.

Liu M, Yang G, Wiehe K, Nicely NI, Vandergrift NA, Rountree W, Bonsignori M, Alam SM, Gao J, Haynes BF, Kelsoe G.

J Virol. 2015 Jan;89(1):784-98. doi: 10.1128/JVI.02378-14. Epub 2014 Oct 29.


Antibody B cell responses in HIV-1 infection.

Mouquet H.

Trends Immunol. 2014 Nov;35(11):549-61. doi: 10.1016/ Epub 2014 Sep 16.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk